Abstract
Objectives: Infectious complications occur in upto 45% of patients following pancreatoduodenectomy (PD) and are higher in patients undergoing preoperative endoscopic invasive procedures. Surgical morbidity adversely affects long-term outcomes and thus role of perioperative antimicrobials needs evaluation. The aim of the study was to compare the impact of Ertapenem administered as 3-once daily perioperative doses on infectious complications in patients at high-risk for complications (underwent preoperative invasive endoscopic procedures) versus those at low-risk (up-front surgery).
Original language | English |
---|---|
Pages (from-to) | e418 |
Number of pages | 1 |
Journal | HPB |
Volume | 18 |
Issue number | Supplement 1 |
DOIs | |
Publication status | Published - Apr 2016 |
Externally published | Yes |
Keywords
- Perioperative
- antimicrobial
- therapy
- pancreatoduodenectomy